These treatment documents were kindly provided for our use by Prof Claire Harrison of Guy’s and St Thomas’ Hospital in London, and MPNVoice, for which MPN AA is extremely grateful.
The information within the documents as they appear on this website has been adapted for Australian patients by Australian haematologists – Dr Cecily Forsyth, Prof Andrew Grigg, and Dr David Ross. We would also like to acknowledge them for their assistance.
Additional treatment documents will be added here in due course.
Frequently Asked Questions
- Anagrelide >
- Aspirin >
- Interferon Alpha >
- Hydroxycarbamide (hydroxyurea) >
- Ruxolitinib >
- Venesection (phlebotomy) >
Myeloproliferative neoplasms (MPN), previously called myeloproliferative disorders (MPD), are a group of diseases that affect normal blood cell production in the bone marrow. In this case the bone marrow causes an overproduction of one or more blood cell types (red cells, white cells or platelets). Complications arise over time due to the abnormally high number of blood cells that accumulate in the bone marrow and in the circulating blood. For more information click here.